PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 213 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,000 | 0.0% | 260 | +23.8% | 0.00% | 0.0% |
| Q3 2019 | $6,000 | +50.0% | 210 | +40.0% | 0.00% | +50.0% |
| Q2 2019 | $4,000 | +33.3% | 150 | +50.0% | 0.00% | 0.0% |
| Q1 2019 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | 0.0% | 100 | -16.7% | 0.00% | 0.0% |
| Q3 2018 | $3,000 | -40.0% | 120 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $5,000 | +25.0% | 120 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $4,000 | -33.3% | 120 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $6,000 | -99.9% | 120 | -36.8% | 0.00% | -50.0% |
| Q3 2017 | $10,266,000 | -3.8% | 190 | 0.0% | 0.01% | -14.3% |
| Q2 2017 | $10,672,000 | +47.4% | 190 | 0.0% | 0.01% | +40.0% |
| Q1 2017 | $7,239,000 | +144680.0% | 190 | 0.0% | 0.01% | +66.7% |
| Q4 2016 | $5,000 | 0.0% | 190 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | +150.0% | 190 | +111.1% | 0.00% | +200.0% |
| Q1 2016 | $2,000 | – | 90 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |